175 related articles for article (PubMed ID: 34111555)
1. Augmenting aer2vec: Enriching distributed representations of adverse event report data with orthographic and lexical information.
Ding X; Mower J; Subramanian D; Cohen T
J Biomed Inform; 2021 Jul; 119():103833. PubMed ID: 34111555
[TBL] [Abstract][Full Text] [Related]
2. Retrofitting Vector Representations of Adverse Event Reporting Data to Structured Knowledge to Improve Pharmacovigilance Signal Detection.
Ding X; Cohen T
AMIA Annu Symp Proc; 2020; 2020():383-392. PubMed ID: 33936411
[TBL] [Abstract][Full Text] [Related]
3. Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.
Winnenburg R; Sorbello A; Ripple A; Harpaz R; Tonning J; Szarfman A; Francis H; Bodenreider O
J Biomed Inform; 2015 Oct; 57():425-35. PubMed ID: 26342964
[TBL] [Abstract][Full Text] [Related]
4.
Portanova J; Murray N; Mower J; Subramanian D; Cohen T
AMIA Annu Symp Proc; 2019; 2019():717-726. PubMed ID: 32308867
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligent Context-Aware Machine-Learning Tool to Detect Adverse Drug Events from Social Media Platforms.
Roosan D; Law AV; Roosan MR; Li Y
J Med Toxicol; 2022 Oct; 18(4):311-320. PubMed ID: 36097239
[TBL] [Abstract][Full Text] [Related]
7. Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance.
Mower J; Cohen T; Subramanian D
Drug Saf; 2020 Jan; 43(1):67-77. PubMed ID: 31646442
[TBL] [Abstract][Full Text] [Related]
8. A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach.
Wang L; Shendre A; Chiang CW; Cao W; Ning X; Zhang P; Zhang P; Li L
Br J Clin Pharmacol; 2022 Feb; 88(4):1471-1481. PubMed ID: 33543792
[TBL] [Abstract][Full Text] [Related]
9. Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System.
Kreimeyer K; Dang O; Spiker J; Muñoz MA; Rosner G; Ball R; Botsis T
Comput Biol Med; 2021 Aug; 135():104517. PubMed ID: 34130003
[TBL] [Abstract][Full Text] [Related]
10. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
[TBL] [Abstract][Full Text] [Related]
11. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
[TBL] [Abstract][Full Text] [Related]
12. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Patel NM; Stottlemyer BA; Gray MP; Boyce RD; Kane-Gill SL
Cardiovasc Drugs Ther; 2022 Apr; 36(2):309-322. PubMed ID: 33599896
[TBL] [Abstract][Full Text] [Related]
13. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
Zhou Z; Hultgren KE
JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
[TBL] [Abstract][Full Text] [Related]
14. Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques.
Kim S; Kang T; Chung TK; Choi Y; Hong Y; Jung K; Lee H
Drug Saf; 2023 Aug; 46(8):781-795. PubMed ID: 37330415
[TBL] [Abstract][Full Text] [Related]
15. Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.
Mower J; Subramanian D; Cohen T
J Am Med Inform Assoc; 2018 Oct; 25(10):1339-1350. PubMed ID: 30010902
[TBL] [Abstract][Full Text] [Related]
16. Adverse Drug Event Prediction Using Noisy Literature-Derived Knowledge Graphs: Algorithm Development and Validation.
Dasgupta S; Jayagopal A; Jun Hong AL; Mariappan R; Rajan V
JMIR Med Inform; 2021 Oct; 9(10):e32730. PubMed ID: 34694230
[TBL] [Abstract][Full Text] [Related]
17. Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.
Karapetiantz P; Audeh B; Redjdal A; Tiffet T; Bousquet C; Jaulent MC
J Med Internet Res; 2024 Jun; 26():e46176. PubMed ID: 38888956
[TBL] [Abstract][Full Text] [Related]
18. Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS).
Xu R; Wang Q
J Biomed Inform; 2014 Feb; 47():171-7. PubMed ID: 24177320
[TBL] [Abstract][Full Text] [Related]
19. BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices.
Dong F; Guo W; Liu J; Patterson TA; Hong H
Front Public Health; 2024; 12():1392180. PubMed ID: 38716250
[TBL] [Abstract][Full Text] [Related]
20. Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis.
Wang L; Rastegar-Mojarad M; Ji Z; Liu S; Liu K; Moon S; Shen F; Wang Y; Yao L; Davis Iii JM; Liu H
Front Pharmacol; 2018; 9():875. PubMed ID: 30131701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
